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Parkinson’s disease (PD) adversely affects timing abilities. Beat-based timing is a mecha-
nism that times events relative to a regular interval, such as the “beat” in musical rhythm, 
and is impaired in PD. It is unknown if dopaminergic medication influences beat-based 
timing in PD. Here, we tested beat-based timing over two sessions in participants with 
PD (OFF then ON dopaminergic medication) and in unmedicated control participants. 
People with PD and control participants completed two tasks. The first was a discrimi-
nation task in which participants compared two rhythms and determined whether they 
were the same or different. Rhythms either had a beat structure (metric simple rhythms) 
or did not (metric complex rhythms), as in previous studies. Discrimination accuracy was 
analyzed to test for the effects of beat structure, as well as differences between partici-
pants with PD and controls, and effects of medication (PD group only). The second task 
was the Beat Alignment Test (BAT), in which participants listened to music with regular 
tones superimposed, and responded as to whether the tones were “ON” or “OFF” the 
beat of the music. Accuracy was analyzed to test for differences between participants 
with PD and controls, and for an effect of medication in patients. Both patients and 
controls discriminated metric simple rhythms better than metric complex rhythms. 
Controls also improved at the discrimination task in the second vs. first session, whereas 
people with PD did not. For participants with PD, the difference in performance between 
metric simple and metric complex rhythms was greater (sensitivity to changes in simple 
rhythms increased and sensitivity to changes in complex rhythms decreased) when ON 
vs. OFF medication. Performance also worsened with disease severity. For the BAT, no 
group differences or effects of medication were found. Overall, these findings suggest 
that timing is impaired in PD, and that dopaminergic medication influences beat-based 
and non-beat-based timing differently. Judging the beat in music does not appear to be 
affected by PD or by dopaminergic medication.
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inTrODUcTiOn
Parkinson’s disease (PD) causes progressive motor and cognitive 
deficits, including deficits in timing (1, 2). Timing deficits in PD 
are likely related to dopaminergic dysfunction in the basal ganglia 
as the striatal dopaminergic system is known to be involved in 
timing (3, 4). One particular type of timing, beat-based timing, 
involves the timing of events relative to a regular interval, or a 
“beat,” such as in musical rhythm. In music, the beat is the regular, 
perceived emphasis to which listeners tend to synchronize their 
movements (e.g., by clapping their hands or tapping their feet). 
Beat-based timing activates the basal ganglia, among other corti-
cal and subcortical regions of the motor system (5–9). There is 
mixed evidence regarding whether the basal ganglia have a specific 
role in beat-based timing compared to other types of timing. One 
study found that both beat-based (relative) and non-beat-based 
(absolute) timing was worse in participants from three clinical 
populations (not including PD) with impaired basal ganglia 
function, compared to control participants (10). This result was 
interpreted as supporting the “unified model” of timing (11), in 
which the basal ganglia play a central role in all types of timing, 
and not specifically in beat-based timing. However, another study 
found that patients with PD had a selective deficit in beat-based 
timing (12). Although both patients and controls discriminated 
metric simple (beat-based) rhythms more accurately than metric 
complex (non-beat-based) rhythms, patients with PD were sig-
nificantly less accurate than controls for metric simple rhythms, 
but not for metric complex rhythms. This finding suggested a 
selective role for the basal ganglia in beat-based timing. However, 
all patients in the study were tested while ON dopaminergic 
medication, thus the influence of dopamine and dopaminergic 
medication on beat-based timing is not well understood.
For timing in PD generally, there is mixed evidence for 
dopaminergic medication’s influence. Dopaminergic medica-
tion improves timing production of participants with PD in 
a task using intervals in the range of 30–120  s, but not in the 
range of 250–2000  ms (13). In addition, participants with PD 
perform more similarly to control participants (with less timing 
variability) on a set of timing tasks while ON medication than 
while OFF (14). A study using behavioral and positron emission 
tomography (PET) found no effect of medication on PD patients’ 
ability to synchronize their tapping with an isochronous tones, 
although dopaminergic denervation was related to tapping accu-
racy (15). Another neuroimaging study (16) found that, although 
dopamine replacement therapy did not improve performance of 
patients with PD in a motor timing task, neural activity increased 
toward the level of controls in the dorsal putamen and supple-
mentary motor area [regions associated with beat perception; (5)] 
during task performances. One study investigated the influence 
of dopaminergic medication on how well participants with PD 
detected beat structure in rhythms (17). Participants with PD 
and controls decided whether rhythms (that were either beat-
based or non-beat-based) had a beat. Participants with PD did 
not significantly differ from controls, for either type of rhythm, 
although numerically participants with PD were worse than 
control participants at the task, and showed less difference in 
performance between beat-based and non-beat-based rhythms 
(control participants were better at recognizing that beat-based 
rhythms indeed had a beat than they were at recognizing that 
non-beat-based rhythms did not have a beat). As both groups had 
a small sample size (n = 9) and there was high variability between 
subjects, a real group difference in beat-based timing could have 
been missed. The study did find a small effect of dopaminergic 
medication: responses were faster when ON vs. OFF medication, 
and those responses were more accurate (though not statisti-
cally significantly). The task required explicit detection of beat 
structure in rhythms, similar to the Beat Alignment Test (BAT) 
in the present study. This explicit nature differs from the rhythm 
discrimination task used previously (12) and in the current study, 
for which an implicit influence of beat-based timing is expected: 
metric simple (beat-based) rhythms should elicit better perfor-
mance than metric complex (non-beat-based rhythms), but no 
explicit awareness of the beat is required or assessed. Thus, there 
is mixed evidence for the influence of dopaminergic medication 
on timing in PD and limited evidence for its influence on beat-
based timing in particular.
The uncertainty regarding dopaminergic medication’s influ-
ence on timing is partly related to the uncertainty regarding the 
extent to which cognitive deficits in PD (including timing) are 
associated with dopamine and would thus be modulated by dopa-
minergic medication. Besides deficient dopamine, other factors 
also contribute to cognitive deficits in the disease, including struc-
tural changes to the brain (18, 19), and accumulation of amyloid 
plaques and tau protein (20, 21). Moreover, the role of dopamine, 
and influence of dopaminergic medication, in cognition is vari-
able, as previous studies show both improvement and worsening 
of different cognitive functions by medication, depending on task 
demands and individual differences in baseline dopamine levels 
(22, 23), as well as side of motor symptom onset (24).
The current study investigated the role of dopaminergic medi-
cation on beat-based timing in individuals with PD. We tested 
participants with PD on two beat perception tasks in two sessions: 
OFF and ON medication. We also tested control participants in 
two sessions, but did not give them medication, to assess practice 
effects. The two tasks were a rhythm discrimination task and the 
BAT [from the Goldsmiths Musical Sophistication Index; (25)]. 
In the discrimination task, participants decided whether two 
rhythms were the same or different. In several studies, the dis-
crimination task has elicited better performance for metric sim-
ple rhythms (beat-based), compared to metric complex rhythms 
(non-beat-based) (5, 12, 26–28). This “beat-based advantage” is 
thought to depend on the beat-based timing (or relative timing) 
mechanism, which is thought to, in turn, depend on basal ganglia 
function (12). The second task, the BAT, presents excerpts of real 
music clips with a sequence of regular tones added to the music. 
The tones are either aligned or misaligned with the beat of the 
music, and participants decide whether the tones were on or off 
the beat of the music.
Both tasks assess beat perception; however, beat perception 
in the discrimination task arises solely on temporal informa-
tion, without the rich variety of acoustic cues present in real 
music. The discrimination task also requires a comparison 
of two separately presented rhythms, introducing a working 
memory component. We hypothesized that if beat-based timing 
TaBle 1 | Trials for rhythm discrimination task.
Metric simple Metric complex
First rhythm second rhythm First rhythm second rhythm
31413 33141
41331 43131 41232
112314 122142
112422 124113
211224 112224 132321 312321
222114 214311 124311
223113 323211 323121
311322 412212 412221
1122114 1121124 1132212
1123113 1123131 1314111 1311411
2113113 2123211 1223211
2211114 2112114 2141211
3121113 3121131 2331111
3122112 1322112 3114111 1314111
4221111 3221112 3212112
Empty cells indicate that the second rhythm was the same as the first.
Numbers indicate relative duration of intervals (1 = 200, 233, or 267 ms).
FigUre 1 | Waveforms of examples of the two types of rhythmic 
sequences, metric simple and metric complex, used as stimuli in the 
rhythm discrimination task. Numbers indicate the relative duration of 
intervals (1 = 200, 233, or 267 ms). Lines indicate tone onsets, and arrows 
indicate beat positions in the metric simple condition.
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depends on basal ganglia function, and is thus impaired in PD, 
dopaminergic medication should improve discrimination of 
metric simple rhythms (but not metric complex rhythms). 
In contrast to the discrimination task, the BAT assesses beat 
perception in the context of real music, meaning that there are 
numerous musical features, unrelated to timing, that empha-
size the beat (e.g., bass timbres or certain chord changes are 
more likely to occur on the beat). Beat perception in the BAT 
therefore does not rely solely on timing cues. The BAT has, 
to the best of our knowledge, not been used in the context 
of PD. If participants with PD perform worse than controls, 
it would provide converging evidence for a deficit in beat 
perception and suggest that other musical cues to the beat do 
not sufficiently compensate for that timing deficit. Similarly, if 
dopaminergic medication improves BAT performance in par-
ticipants with PD, then beat perception in real musical contexts 
is likely dependent on basal ganglia function. Alternatively, if 
the groups do not differ, and/or there is no effect of medica-
tion on BAT performance, then beat perception arising from 
non-temporal cues likely does not rely on intact dopaminergic 
function of the basal ganglia.
MaTerials anD MeThODs
Participants
Participants with PD were recruited from the St. Louis, MO, 
USA region to participate in an ongoing study investigating 
interventions for improving gait in PD. The data from these 
participants (n = 72, 30 female, mean age 66.8 years, SD = 9.4, 
mean of 2.18  years of musical training) are the baseline data, 
collected before any intervention, and only from participants 
who were taking dopaminergic medication at the time of test-
ing. Controls (n = 70, 50 female, mean age 67.6 years, SD = 9.0, 
mean of 3.37 years of musical training) were recruited from the 
London, ON, Canada region. All participants scored at least 
27 on the Mini Mental State Examination. Group differences 
in age and mean years of musical training were not statistically 
significant (p >  0.05). Participants’ highest achieved education 
levels were scored from 1 (high school) to 4 (advanced degree), 
and the groups did not differ on this measure (mean PD educa-
tion = 2.79, SD = 1.05, mean control education = 2.90, SD = 1.07, 
p > 0.05). All participants provided informed, written consent in 
accord with procedures approved by the respective ethics boards 
at Western University and Washington University School of 
Medicine.
stimuli
For the rhythm discrimination task, two types of rhythms were 
used: metric simple and metric complex (see Figure  1). The 
stimuli are described in detail elsewhere (12). Both types are 
composed of intervals that are related by small integer-ratios, and 
were presented in one of three tempi, corresponding to the short-
est interval duration (i.e., rhythms consisted of interval durations 
of 1, 2, 3, and 4, in which “1” was equal to 200, 233, or 267 ms, “2” 
was twice the duration of “1,” etc.). The trials used were a subset of 
the trials used in a previous study (12), and are listed in Table 1.
For the BAT [from the Goldsmiths Musical Sophistication 
Index; (25)], stimuli were 17 excerpts of music in which an isoch-
ronous tone sequence was embedded. The tone sequence could 
either be aligned with the beat of the music (“on beat,” four trials), 
faster or slower than the musical beat (period-shifted, eight tri-
als), or at the same beat rate, but misaligned to the musical beat 
(phase-shifted, five trials).
Procedure
Testing consisted of completing each task twice in the same day, 
with between 30 and 90 min separating the two testing sessions. 
Participants with PD were OFF medication in the first session 
(participants were asked to withhold all anti-Parkinson’s medica-
tion for at least 12  h prior to the session) and ON medication 
in the second session [all participants with PD were regularly 
taking levodopa (l-DOPA), typically in combination with car-
bidopa, except one participant who was taking rasagiline and 
pramipexole, one who was taking amantadine and pramipexole, 
FigUre 2 | Mean rhythm discrimination scores (adjusted for musical 
training and education) collapsed across rhythm type for both 
groups, in both sessions. Error bars indicate ± 1 SEM.
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and another who was taking ropinirole]. Between testing ses-
sions, participants completed the MMSE and a questionnaire 
about their musical training. Additionally, participants with PD 
completed the Movement Disorders Society Unified Parkinson’s 
Disease Rating Scale [MDS-UPDRS; Ref. (29)].
Participants completed both tasks on laptops. Auditory 
stimuli were presented via headphones, and instruction text was 
presented on the laptop display. For the rhythm discrimination 
task, participants heard three consecutive rhythms (see Stimuli) 
and responded whether they thought the final rhythm was the 
same as the first two (which were always identical). During the 
two presentations of the first rhythm, the text “Original rhythm: 
First listen” and “Original rhythm: Second listen” were displayed, 
respectively, in white text. During presentation of the final, 
comparison, rhythm, the text “SECOND rhythm” was displayed 
in red text. Following presentation of the second rhythm, “Was 
the SECOND rhythm the same or different? If same, press (S). If 
different, press (D)” was displayed in white text. Participants then 
indicated whether they thought the second rhythm was the same 
as or different from the original rhythm. Four practice trials were 
completed before testing.
For the BAT, participants completed 17 trials (see Stimuli) in 
random order. Participants were given verbal instructions to lis-
ten to each music excerpt and to respond whether the embedded 
tone sequence was “ON” or “OFF” the beat of the music. During 
listening, the laptop display read “Please Listen,” and following 
each excerpt, it read “Are the tones on or off the beat? Press “y” 
for YES or “n” for NO on the keyboard.” Three practice trials were 
completed before testing.
analyses
Rhythm discrimination scores (proportion of correct trials) were 
initially analyzed in a 2 ×  2 ×  2 mixed analysis of covariance 
(ANCOVA) with the between-subjects factor of group (PD vs. 
control), and the within-subject factors of session (first vs. second 
session, also corresponding to OFF vs. ON medication for the 
participants with PD) and metricality of rhythms (metric simple 
vs. metric complex), and including the covariates musical train-
ing (years) and education level (both mean-centered separately 
for the two groups). Analyses were repeated without covariates 
that were non-significant and/or did not interact with other fac-
tors in the initial analysis.
As our primary research interest was the relationship between 
beat perception and dopaminergic medication [known to influ-
ence cognition in PD; (30)], and because we were unable to test 
the healthy controls ON medication, we conducted a separate 
2 ×  2 ANCOVA on the PD patient data alone. This ANCOVA 
included the within-subject factors medication (OFF vs. ON) and 
metricality (metric simple vs. metric complex), and the covariate 
of MDS-UPDRS (subscale III, off medication, mean-centered).
Furthermore, as only a subset of trials from the previous 2009 
study (12) were used in the discrimination task (due to limita-
tions of testing time), data from the 2009 study were reanalyzed 
to include only the subset of trials that were used in this current 
study. Results from the 2009 study and current study (ON and 
OFF medication, separately) were compared using independent 
samples t tests.
Beat alignment test scores (proportion of correct trials) were 
analyzed in a 2 × 2 mixed ANCOVA with the between-subjects 
factor of group (control vs. PD) and within-subject factor of 
session (first vs. second session, also corresponding to OFF vs. 
ON medication for the participants with PD), and musical train-
ing and education (both mean-centered, separately for the two 
groups) as covariates.
resUlTs
rhythm Discrimination
Participants with PD were worse than control participants at 
discriminating rhythms [main effect of group, F(1,136) = 10.86, 
p = 0.001, ηp2 0 0= . 74]. In the second session, control participants 
performed better than in the first session, and participants with 
PD did not show this improvement [a statistical trend toward 
an interaction of group and session, F(1,136) = 3.31, p = 0.071, 
ηp
2 0 0= . 24], confirmed by follow-up paired t tests comparing aver-
age scores within each session for healthy controls, [t(68) = 2.22, 
p = 0.030, and for participants with PD, p > 0.05], as shown in 
Figure  2. Overall, discrimination was better for metric simple 
rhythms than for metric complex rhythms [main effect of met-
ricality, F(1,136) = 36.50, p < 0.001, ηp2 0= .212 ]. This effect of 
metricality was present for both groups in both sessions (p < 0.05, 
in all cases), as shown in Figure 3. Regarding musical training, 
there was a statistical trend toward those more training being 
better at discriminating rhythms [F(1,136) =  3.77, p =  0.054, 
ηp
2 0 0= . 27]. Although education level was not a significant 
covariate, there was a trend toward education interacting with 
metricality [F(1,136) = 3.63, p = 0.059, ηp2 0 0= . 26]. Follow-up 
comparisons of these data show that trends were in opposite 
directions: those with more education tended to do better with 
metric complex rhythms and slightly worse with metric simple 
rhythms. The three-way interaction between group, session, and 
metricality did not reach significance (p > 0.1).
Analysis of only the data from participants with PD shows 
that metric simple rhythms were discriminated better than metric 
FigUre 4 | MDs-UPDrs scores and rhythm discrimination scores 
from participants with PD (discrimination scores are collapsed over 
OFF and On medication conditions).
FigUre 3 | Mean rhythm discrimination scores (adjusted for musical 
training and education) for both groups, in both sessions, and for 
both metrical types of rhythms.
FigUre 5 | Mean rhythm discrimination scores (unadjusted) from the 
current sample of participants with PD (OFF and On dopaminergic 
medication) and from a previous study (On medication only, and 
recalculated to include only the trials used in the current study).
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complex rhythms [main effect of metricality, F(1,69) =  29.81, 
p <  0.001, ηp2 0 0= .3 2], as is evident in Figure  3. The effect of 
metricality was larger when participants were ON medica-
tion compared to OFF medication [interaction of metricality 
and medication, one-tailed, as the direction of differences was 
hypothesized, F(1,69) = 2.77, p = 0.050, ηp2 0 0= . 39]. A paired 
t-test of the difference scores (metric simple minus metric 
complex, adjusted for UPDRS) confirmed a significantly greater 
difference while ON vs. OFF medication [t(70) = 1.69, p = 0.048]. 
Follow-up t tests indicated that metric simple scores numerically 
increased and metric complex scores numerically decreased from 
OFF to ON sessions, although neither change was statistically 
significant (p > 0.05).
Movement Disorders Society Unified Parkinson’s Disease 
Rating Scale scores (off medication) significantly covaried with 
overall discrimination performance [F(1,69) = 11.49, p = 0.001, 
ηp
2 0= .143], as shown in Figure 4. MDS-UPDRS scores and mean 
discrimination scores (averaged over sessions and metricalities) 
negatively correlate (rSp = −0.32, p = 0.007). Although there was 
no significant interaction between MDS-UPDRS, medication, 
and task performance, exploratory analysis showed that per-
formance negatively correlated with MDS-UPDRS scores both 
OFF and ON medication (rSp = −0.28, p = 0.020 and rSp = −0.36, 
p = 0.002, respectively).
We compared the results from our current participants with 
PD to the results of the 2009 study using the same task (with pre-
vious data recalculated to include only the same trials used in the 
present study). The 2009 sample was participants with PD, ON 
medication with one session of testing [n = 15; (12)]. The current 
ON medication sample was numerically more similar to the 2009 
sample (also ON medication) than to the current OFF medication 
sample. Overall, however, independent samples t tests comparing 
the 2009 sample and the current sample ON and OFF medication 
(separately) show no statistically significant differences (p > 0.05) 
between discrimination scores for either metric simple or metric 
complex rhythms (see Figure 5). Thus, when including identical 
trials between the 2009 sample and the current sample, the two 
groups of patients did not differ in performance.
Beat alignment Test
Performance on the BAT did not differ between groups, or 
between sessions (see Figure 6). BAT scores were not associated 
with musical training or education, or MDS-UPDRS scores in 
participants with PD. Furthermore, BAT scores did not correlate 
with mean discrimination scores (p > 0.05). When analyzing data 
from participants with PD alone, we found no effect of medica-
tion or interactions involving medication (p > 0.05).
DiscUssiOn
Overall, the rhythm discrimination task was sensitive to tim-
ing deficits in PD: participants with PD performed worse than 
control participants, and participants more severely affected by 
PD (those with higher MDS-UPDRS scores) did worse than those 
less affected. Furthermore, control participants improved over 
the two sessions while participants with PD did not, suggesting 
that in addition to a deficit in timing, they may be less able to 
FigUre 6 | Mean scores (proportion of correct trials) for the Beat 
alignment Test. Error bars indicate ± 1 SEM.
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Regarding the discrimination task, we found mixed results. 
Contrary to our expectation, we did not see a clear deficit in beat 
perception associated with PD. Participants with PD performed 
better on the task for metric simple (beat-based) rhythms 
than for metric complex (non-beat-based) rhythms, similar 
to control participants. This is at odds with the finding from a 
previous study that used the same two types of rhythms in the 
same rhythm discrimination task, showing that the beat-based 
advantage (superior discrimination of metric simple rhythms) 
was significantly reduced in PD compared to controls. However, 
when results from the previous study were recalculated to include 
only the exact same trials used in the current study, the differ-
ence in performance between metric simple and metric complex 
rhythms increased, and closely resembled that of the current 
data (see Figure 5), suggesting that our current study did indeed 
replicate the previous results. Moreover, the previous study’s 
recalculated data most closely resembles the ON medication 
data from the current study. This is notable as participants in the 
previous study were ON medication. The dependence of perfor-
mance on the specific trials included demonstrates a potential 
limitation of discrimination tasks: performance is dependent 
not just on condition differences (rhythms are easier to encode 
and maintain when participants perceive a beat, therefore per-
formance is generally better for beat-based rhythms) but also 
the specific nature of the discrimination being made. The task 
required participants to detect whether a change occurred in the 
rhythm, and the change, when present, was always a transposi-
tion (or swapping) of two time intervals. For example, the rhythm 
211314 could become 211134. Some transpositions are easier to 
detect than others. Changes to the beginning or end of a rhythm 
are easier to detect than those in the middle because of primacy 
and recency effects (36). In addition, transposition of disparate 
intervals (e.g., 3 and 1) may be easier to detect than transposition 
of more similar intervals (e.g., 3 and 4). Thus, by reducing the 
number of trials selected for the current study, the results could 
be more influenced by these trial-specific differences that are not 
related to beat perception, but are instead related to the specific 
nature and location of the change in the rhythm. However, as 
the current results do not differ from the previous results (which 
used a much larger set of trials) when reanalyzed to include 
only the same trials, we feel it reasonable to interpret the cur-
rent findings as replicating the previous finding that beat-based 
timing is impaired in PD, although trial selection influenced the 
exact pattern of results. Further support for a beat-based timing 
impairment needs to be acquired. This may be best accomplished 
by using different tasks, such as rhythm reproduction that do not 
have the limitations present in discrimination tasks.
For participants with PD, the difference in discrimination 
performance between metric simple and metric complex 
rhythms increased when ON vs. OFF dopaminergic medication. 
The data therefore suggest that medication influences beat-based 
timing in PD, although the pattern of the influence is complex. 
In particular, the worsening of performance for metric complex 
(non-beat-based) rhythms was unexpected. The improvement of 
performance for beat-based rhythms may be due to dopaminergic 
medication improving basal ganglia function, as they are thought 
to play a critical role in beat perception. Another possibility is 
learn from repetition of the timing task. Although we did not 
expect this result, and do not consider it a primary finding of the 
study, it is consistent with previous evidence of learning deficits 
in PD. For example, patients with PD show less consolidation 
than controls after learning a motor control task (31), and slower 
re-learning after disruption of a previously learned motor task 
(32). Moreover, dopaminergic medication can change the nature 
of learning in PD (33–35), possibly contributing to the lack of 
improvement in discrimination task performance from session 1 
(OFF medication) to session 2 (ON medication) in PD. However, 
as the repetition of the task is confounded with medication 
status in participants with PD (the first session was always OFF 
medication, followed by ON medication in the second session), 
we cannot fully disentangle effects of repetition and medication 
in participants with PD.
The BAT was not sensitive to timing deficits in PD, as per-
formance on the task by control participants and those with PD 
did not significantly differ. The additional information in real 
music may give listeners with PD sufficient cues regarding the 
beat, such that beat-based timing deficits do not impair task 
performance. In addition to the other musical cues to the beat 
that are present in the BAT, participants compare simultaneously 
presented sequences (the beat in the musical stimulus, and the 
overlaid tone sequence). The discrimination task, by comparison, 
requires a memory-based judgment, which requires the encod-
ing, rehearsal, and retrieval of a rhythm. These processes involve 
the internal generation of rhythms, which is supported by the 
presence of temporal structure, such as the beat. Thus, the differ-
ence in cognitive processes required by the BAT and the rhythm 
discrimination task may underlie the difference in findings 
between tasks regarding the particular nature of timing deficits in 
PD. Consistent with this interpretation, performance on the BAT 
and discrimination task did not correlate, suggesting that these 
tasks are indeed sensitive to different aspects of beat perception, 
and rely on different underlying cognitive processes. Although 
BAT performance was numerically better for control participants 
than participants with PD, the large sample sizes suggest that any 
potential difference between patients and controls is small.
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that dopaminergic medication biases participants to search for 
a beat structure. This bias would improve performance for beat-
based rhythms, in which a beat structure can be detected, and 
therefore searching for it is beneficial, but the same bias would 
worsen performance for metric complex rhythms, in which the 
beat structure is difficult to find, and attempting to search for it 
distracts from using another, better, strategy to remember the 
rhythms. As mentioned above, task repetition (first vs. second 
session) is confounded with medication (OFF vs. ON); however, 
the metricality-dependent change in performance (improved 
performance for metric simple rhythms and worsened perfor-
mance for metric complex rhythms) is less likely due to repetition 
than to medication. An expected effect of repetition would be 
improved performance for one or both types of rhythms, but 
not worse performance. As such, we interpret the overall lack of 
improvement at the task as a deficit in learning the task (com-
pared to control participants’ overall improvement from the first 
to second session), but the different direction of performance 
change for metric simple and metric complex rhythms as an effect 
of medication on beat-based timing.
Overall, these data present further evidence that timing is 
impaired in individuals with PD (and worsens with severity of 
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